Your browser doesn't support javascript.
loading
The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
Rebello, Richard J; Kusnadi, Eric; Cameron, Donald P; Pearson, Helen B; Lesmana, Analia; Devlin, Jennifer R; Drygin, Denis; Clark, Ashlee K; Porter, Laura; Pedersen, John; Sandhu, Shahneen; Risbridger, Gail P; Pearson, Richard B; Hannan, Ross D; Furic, Luc.
Afiliação
  • Rebello RJ; Cancer Program, Biomedicine Discovery Institute and Department of Anatomy & Developmental Biology, Monash University, Victoria, Australia.
  • Kusnadi E; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.
  • Cameron DP; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.
  • Pearson HB; Department of Cancer Biology and Therapeutics, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
  • Lesmana A; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.
  • Devlin JR; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.
  • Drygin D; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia.
  • Clark AK; Pimera, Inc. San Diego, California.
  • Porter L; Cancer Program, Biomedicine Discovery Institute and Department of Anatomy & Developmental Biology, Monash University, Victoria, Australia.
  • Pedersen J; Cancer Program, Biomedicine Discovery Institute and Department of Anatomy & Developmental Biology, Monash University, Victoria, Australia.
  • Sandhu S; TissuPath Pathology, Melbourne, Victoria, Australia.
  • Risbridger GP; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
  • Pearson RB; Cancer Program, Biomedicine Discovery Institute and Department of Anatomy & Developmental Biology, Monash University, Victoria, Australia.
  • Hannan RD; Oncogenic Signaling and Growth Control Program, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Victoria, Australia. luc.furic@monash.edu ross.hannan@anu.edu.au rick.pearson@petermac.org.
  • Furic L; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia.
Clin Cancer Res ; 22(22): 5539-5552, 2016 Nov 15.
Article em En | MEDLINE | ID: mdl-27486174
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Transcrição Gênica / RNA Polimerase I / Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-pim-1 / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Transcrição Gênica / RNA Polimerase I / Inibidores de Proteínas Quinases / Proteínas Proto-Oncogênicas c-pim-1 / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Ano de publicação: 2016 Tipo de documento: Article